Zura Bio Statistics
Total Valuation
Zura Bio has a market cap or net worth of $68.68 million. The enterprise value is -$101.89 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, before market open.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Zura Bio has 61.87 million shares outstanding. The number of shares has increased by 97.21% in one year.
| Current Share Class | 61.87M |
| Shares Outstanding | 61.87M |
| Shares Change (YoY) | +97.21% |
| Shares Change (QoQ) | +2.22% |
| Owned by Insiders (%) | 7.26% |
| Owned by Institutions (%) | 43.75% |
| Float | 25.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.55 |
| P/TBV Ratio | 0.50 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.14
| Current Ratio | 8.14 |
| Quick Ratio | 8.09 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -55.05% and return on invested capital (ROIC) is -36.60%.
| Return on Equity (ROE) | -55.05% |
| Return on Assets (ROA) | -31.40% |
| Return on Invested Capital (ROIC) | -36.60% |
| Return on Capital Employed (ROCE) | -43.63% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.07M |
| Employee Count | 30 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -78.81% in the last 52 weeks. The beta is 0.04, so Zura Bio's price volatility has been lower than the market average.
| Beta (5Y) | 0.04 |
| 52-Week Price Change | -78.81% |
| 50-Day Moving Average | 1.28 |
| 200-Day Moving Average | 2.63 |
| Relative Strength Index (RSI) | 39.10 |
| Average Volume (20 Days) | 428,863 |
Short Selling Information
The latest short interest is 2.49 million, so 4.02% of the outstanding shares have been sold short.
| Short Interest | 2.49M |
| Short Previous Month | 2.59M |
| Short % of Shares Out | 4.02% |
| Short % of Float | 9.88% |
| Short Ratio (days to cover) | 6.00 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -66.06M |
| Pretax Income | -58.52M |
| Net Income | -62.10M |
| EBITDA | n/a |
| EBIT | -66.06M |
| Earnings Per Share (EPS) | -$0.72 |
Full Income StatementBalance Sheet
The company has $170.57 million in cash and n/a in debt, giving a net cash position of $170.57 million or $2.76 per share.
| Cash & Cash Equivalents | 170.57M |
| Total Debt | n/a |
| Net Cash | 170.57M |
| Net Cash Per Share | $2.76 |
| Equity (Book Value) | 151.40M |
| Book Value Per Share | 2.02 |
| Working Capital | 150.60M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$34.16 million and capital expenditures -$117,000, giving a free cash flow of -$34.27 million.
| Operating Cash Flow | -34.16M |
| Capital Expenditures | -117,000 |
| Free Cash Flow | -34.27M |
| FCF Per Share | -$0.55 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |